We have previously characterized the fragile histidine-triad protein hFhit as a new β-catenin interaction partner and repressor of β-catenin transcriptional activity [16, 17], providing a new molecular mechanism for the hFhit tumour suppressor function. The gene discussed is FHIT; the disease is neoplasm.